NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 1)
key details
| Value | £424,035,364 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Deadline | 23 Nov 2023 |
| Contract start | 1 Jun 2024 |
| Contract end | 31 May 2027 |
| Procedure | open |
| SME suitable | Yes |
| OCID | ocds-b5fd17-92e06515-73f7-4927-9db0-0ae5cae7907f |
Awards (63)
This procurement was awarded to 63 suppliers. Values shown are per-award; the notice total is £424,035,364.
| Supplier | Value | Date | Status |
|---|---|---|---|
| Abbvie Ltd shared | £1 | 4 Mar 2024 | active |
| AGB Pharma shared | £1 | 4 Mar 2024 | active |
| Aguettant Ltd shared | £1 | 4 Mar 2024 | active |
| Alissa Healthcare Research Limited shared | £1 | 4 Mar 2024 | active |
| Amarox Limited shared | £1 | 4 Mar 2024 | active |
| Aspire Pharma Limited shared | £1 | 4 Mar 2024 | active |
| Aventis Pharma ltd t/a Sanofi shared | £1 | 4 Mar 2024 | active |
| B. Braun Medical Limited shared | £1 | 4 Mar 2024 | active |
| Bowmed Ibisqus Limited shared | £1 | 4 Mar 2024 | active |
| Colonis Pharma Ltd shared | £1 | 4 Mar 2024 | active |
| Consilient Health Ltd shared | £1 | 4 Mar 2024 | active |
| CST Pharma Limited shared | £1 | 4 Mar 2024 | active |
| Day Lewis Medical Ltd shared | £1 | 4 Mar 2024 | active |
| Desitin Pharma Ltd shared | £1 | 4 Mar 2024 | active |
| Dr.Reddy's Laboratories (UK) Limited shared | £1 | 4 Mar 2024 | active |
| ennogen healthcare ltd shared | £1 | 4 Mar 2024 | active |
| Esteve Pharmaceuticals Ltd shared | £1 | 4 Mar 2024 | active |
| Flexipharm Austrading Limited shared | £1 | 4 Mar 2024 | active |
| FLYNN PHARMA LTD shared | £1 | 4 Mar 2024 | active |
| Fresenius Kabi Limited shared | £1 | 4 Mar 2024 | active |
| GENNISIUM PHARMA shared | £1 | 4 Mar 2024 | active |
| Gerot Lannach UK Ltd shared | £1 | 4 Mar 2024 | active |
| GH Pharma Ltd shared | £1 | 4 Mar 2024 | active |
| GlaxoSmithKline UK Limited shared | £1 | 4 Mar 2024 | active |
| Glenmark Pharmaceuticals Europe Limited shared | £1 | 4 Mar 2024 | active |
| hameln pharma ltd shared | £1 | 4 Mar 2024 | active |
| Healthcare Pharma Ltd shared | £1 | 4 Mar 2024 | active |
| Ipca Laboratories UK Ltd shared | £1 | 4 Mar 2024 | active |
| Janssen-Cilag Ltd shared | £1 | 4 Mar 2024 | active |
| Kent Pharma Ltd shared | £1 | 4 Mar 2024 | active |
| Lucane Pharma shared | £1 | 4 Mar 2024 | active |
| Macleods Pharma UK Limited shared | £1 | 4 Mar 2024 | active |
| Martindale Pharma shared | £1 | 4 Mar 2024 | active |
| medac Pharma LLP shared | £1 | 4 Mar 2024 | active |
| Medreich PLC shared | £1 | 4 Mar 2024 | active |
| Mercury Pharmaceuticals Limited shared | £1 | 4 Mar 2024 | active |
| Milpharm Ltd/aurobinbdo Primary shared | £1 | 4 Mar 2024 | active |
| Morningside Pharmaeuticals shared | £1 | 4 Mar 2024 | active |
| Mylan shared | £1 | 4 Mar 2024 | active |
| Neuraxpharm UK Ltd shared | £1 | 4 Mar 2024 | active |
| Novumgen Limited shared | £1 | 4 Mar 2024 | active |
| Organon Pharmaceuticals UK Ltd shared | £1 | 4 Mar 2024 | active |
| Otsuka Pharmaceuticals UK Limited shared | £1 | 4 Mar 2024 | active |
| Panpharma UK Limited shared | £1 | 4 Mar 2024 | active |
| PARI shared | £1 | 4 Mar 2024 | active |
| Perennial Pharma Ltd shared | £1 | 4 Mar 2024 | active |
| Pfizer Ltd shared | £1 | 4 Mar 2024 | active |
| Piramal Critical care Limited shared | £1 | 4 Mar 2024 | active |
| Roma Pharmaceuticals Limited shared | £1 | 4 Mar 2024 | active |
| Rosemont Pharmaceuticals Limited shared | £1 | 4 Mar 2024 | active |
| ROVI Biotech Ltd shared | £1 | 4 Mar 2024 | active |
| Sandoz Ltd shared | £1 | 4 Mar 2024 | active |
| Seacross Pharmaceuticals Ltd shared | £1 | 4 Mar 2024 | active |
| Selective Supplies Ltd. shared | £1 | 4 Mar 2024 | active |
| Sobi (Swedish Orphan Biovitrum Ltd) shared | £1 | 4 Mar 2024 | active |
| Sun Pharma UK Ltd shared | £1 | 4 Mar 2024 | active |
| Teva UK Limited shared | £1 | 4 Mar 2024 | active |
| Thornton and Ross Ltd shared | £1 | 4 Mar 2024 | active |
| Tillotts Pharma UK Ltd shared | £1 | 4 Mar 2024 | active |
| Torbay Pharmaceuticals shared | £1 | 4 Mar 2024 | active |
| Venture Healthcare Ltd shared | £1 | 4 Mar 2024 | active |
| Wockhardt UK Limited shared | £1 | 4 Mar 2024 | active |
| Zentiva Pharma UK Ltd shared | £1 | 4 Mar 2024 | active |
description
Invitation to offer for NHS National Generic Pharmaceuticals - Wave 14c Offer reference number: CM/PHG/22/5672
Period of framework agreement: The total maximum duration of the framework agreement to be no more than 36 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months.
Potential periods of call-offs under the framework agreement: Orals (plus non-parenteral) Products: All Regions (CESW/LSNE/NWLN):01/06/2024 to 31/05/2027 (36 Months) Hospital Only Products: DLS & DNE: 01/06/2024 to 31/05/2026(24 months) Hospital Only Products(Housekeeping): DLN & DNW: 01/06/2024 to 31/01/2025(8 months) DCE & DSW: 01/06/2024 to 30/09/2025(16 months)
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 14 May 2024 | Award (award) | · | a61d79ec-c723-4171-8941-70f546470f90-750811 |
more from NHS England
- Urgent Award - haematological screening · £16,202 · 29 Jul 2026
- HSCN-AWS Connectivity Service for Spine · £228,060 · 29 Jul 2026
- Incentive Voucher Provider · £60,000 · 29 Jul 2026
- CRM for NHSE participant/candidate data 26-27 · £56,640 · 28 Jul 2026
- Wayfinder and First Contact Digital Clinical Support 2026-27 · £748,000 · 23 Jul 2026
- Support Services for PPM application · £860,000 · 22 Jul 2026
- Digital Maturity Assessment · 21 Jul 2026
- Integrated Healthcare Services to Haslar Immigration Removal Centre (IRC) · £19,052,186 · 13 Jul 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.